Zydus Lifesciences gets USFDA's nod to market generic version of Bortezomib

The drug, a generic version of reference listed drug Velcade, will be manufactured at Zydus Hospira, Gujarat.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/lOhVIcB
via IFTTT